Zero to Hero?

Scope 3 Emissions – A Strategic Imperative for Pharma Companies

Read more

Related Insights

Life Sciences & Pharma

Innovation in Animal Health: Turning Potential into Progress

October 14, 2025

Executive Insights

Life Sciences & Pharma

From Bench to Bedside: Academic-to-Industry Translation in European Biopharma

June 25, 2025

Video / Webinar

Sustainability

The Power of Agility in Sustainability

June 9, 2025

Executive Insights

Life Sciences & Pharma

Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies

April 17, 2025

Life Sciences & Pharma

Optimizing Four-Wall DC Operations for a Pharmaceutical Distributor

March 27, 2025

After years of stable but stagnant warehouse performance, a major pharmaceutical distributor sought to modernize its technology infrastructure to boost…

Life Sciences & Pharma

AI and Biopharma: New Solutions Emerging Across the US Value Chain

December 6, 2024